ICPT - Intercept surges after agreeing to $19/share offer from Alfasigma
2023-09-26 09:01:36 ET
More on Intercept
- Seeking Alpha’s Quant Rating on Intercept Pharma
- Historical earnings data for Intercept Pharma
- Intercept: Narrowed Market, Concentrated Strategy (Rating Upgrade)
- Intercept Pharma beats Q2 top and bottom line estimates; updates FY23 outlook
- Intercept Pharma gains on H.C. Wainwright double upgrade
For further details see:
Intercept surges after agreeing to $19/share offer from Alfasigma